Dr. Shaan Mohammed Raza, MD

Dr. Raza practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Raza's NPI, 1992842751, was assigned on January 31, 2007. Dr. Raza graduated from The Johns Hopkins University School of Medicine in 2006. Dr. Raza holds Texas license P6507.

Dr. Raza's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Raza's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Texas Children's Hospital. Dmand AI also links Dr. Raza to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raza practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Raza's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Raza is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Raza's licenses on file in 12 states: Texas, Florida, Arizona, Georgia, Mississippi, Washington, Alabama, Louisiana, Oklahoma, Tennessee, New York and Maryland.

Dmand AI lists craniotomy among the conditions Dr. Raza treats.

CMS data shows 74 Medicare services from Dr. Raza across 2 procedure codes in 2024, for 75 Medicare patients. Medicare paid $9,323 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Raza in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raza's median patient age at 68, with 57% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Raza for performance year 2024, reported as part of a group. Dr. Raza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raza as offering telehealth.

Dmand AI links 154 papers to Dr. Raza, published from 2009 to 2025. 2023 was the busiest year, with 13. The most frequent topics are Skull Base Neoplasms, Magnetic Resonance Imaging and Skull Base. Dr. Raza has published most often in J Neurol Surg B Skull Base. Dr. Raza's most frequent co-authors are Ehab Y. Hanna, MD, Shirley Y. Su, MD and Michael Elliot Kupferman, MD.

Dmand AI links Dr. Raza to 1 clinical trial. Conditions studied include Meningioma and Meningeal Neoplasms.

CMS Open Payments shows 67 general payments to Dr. Raza from 3 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Medtronic, Inc. paid the most, $22,647.

Dmand AI lists 20 awards for Dr. Raza, most recently Honor Appointed to Medical Advisory Board in 2023. Dr. Raza serves on Research Committee North American Skull Base Society.

Dr. Raza graduated from The Johns Hopkins University School of Medicine in 2006. Dr. Raza is a member of AANS and CNS.

Dr. Raza is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.